The Case Against.

The article focuses on the public and political debate surrounding the availability and use of cannabis-based medicines (CBMs) for therapeutic purposes. Topics discussed include history of curative and recuperative powers of thalidomide used in Australia, effectiveness, safety and cost factor of cannabis or its derivatives, and need for randomized controlled trials to determine effectiveness.